Neurology® Podcast

American Academy of Neurology
undefined
Nov 12, 2026 • 13min

Establishing Potosi Virus as a Human Pathogen - Part 2

Justin Abbatemarco, a neurologist and clinician-researcher specializing in autoimmune neurology and neuroinfections, discusses infection risks during immunosuppressive therapy. Topics include IVIG for severe viral infections, vaccination during B-cell therapy, seasonal exposure, unexplained cognitive decline, Good syndrome, advanced infection-risk assessment, and measles immunity before treatment.
undefined
Nov 9, 2026 • 19min

Establishing Potosi Virus as a Human Pathogen - Part 1

Justin Abbatemarco, a Cleveland Clinic autoimmune neurologist specializing in neuroimmunology, discusses a fatal Potosi virus encephalitis case in a patient receiving rituximab. He explores why infections can hide during anti-CD20 therapy, when to use advanced sequencing, enterovirus risks, vaccination and immune assessment, everyday and vector-borne exposures, and how lab collaboration can reveal overlooked pathogens.
undefined
Nov 5, 2026 • 26min

Physicians as Patients: A Live On-stage Discussion

Franziska Herpich, a neurointensivist and stroke specialist, recounts surviving a TIA and stroke at 33 and navigating care from the patient side. Yolanda Holler-Managan, a child neurologist focused on neurodevelopmental disabilities, shares her son’s autism diagnosis and the realities of caregiving. They discuss recovery, vulnerability, stigma, empathy, and thoughtfully sharing lived experience with families.
undefined
7 snips
Nov 3, 2026 • 15min

Youth Football and the Epidemic of Pediatric Brain Injury

Isaac Thorman, a medical student studying traumatic brain injury and neurology, explores football’s disproportionate concussion burden among young athletes. He discusses links to later anxiety, mood disorders, learning difficulties, and ADHD, why developing brains may be more vulnerable, and the risks of repeat injuries. The conversation also considers safer tackling policies, concussion protocols, equipment, supervision, and preserving sports’ benefits.
undefined
Nov 1, 2026 • 1h 11min

November 2026 Recall: Updates in Neurodegenerative Disease: Diagnosis, Treatment, and Prevention

Pascal Geldsetzer, Stanford physician-epidemiologist; Eric Minikel and Sonia Vallabh, Broad Institute prion researchers; and dementia specialists Trey Bateman and Gregg Day explore 2026 Alzheimer’s breakthroughs, from blood biomarkers and anti-amyloid therapies to tau targeting and prevention. They examine first-in-human prion treatments, earlier diagnosis, and preventive trials, then discuss intriguing evidence that shingles vaccination may reduce dementia risk.
undefined
8 snips
Oct 29, 2026 • 16min

Trends in Emergent Interfacility Ischemic Stroke Transfers

Matthew Gusler, a vascular neurologist and Ohio State assistant professor, discusses nationwide trends in emergency transfers for ischemic stroke. He examines which patient, demographic, and facility factors shape transfer decisions, why rates declined after 2020, and the possible roles of telehealth, triage, local capabilities, and hospital capacity. He also explores data limitations and the future of stroke care systems.
undefined
9 snips
Oct 26, 2026 • 26min

Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

Michel Toledano, a Mayo Clinic neurologist specializing in neuroimmunology and neuroinfectious disease, examines a postpartum woman with MS who develops rapidly progressive brainstem symptoms. The discussion explores cranial neuropathies, weakness, ataxia, rhombencephalitis imaging, pregnancy-related treatment considerations, misleading HHV-6 testing, chromosomal integration, and the eventual diagnosis of enteroviral CNS infection.
undefined
7 snips
Oct 22, 2026 • 13min

Incidence and Prevalence of Conversions to MCI and Dementia in Patients With Essential Tremor

Elan Louis, UT Southwestern neurology chair and movement-disorders researcher, explores essential tremor beyond its motor symptoms. He discusses rates of mild cognitive impairment and dementia, findings from the deeply characterized Cognet cohort, comparisons with Parkinson’s disease, Alzheimer-type pathology, tau biology, and emerging blood-based biomarkers. He also considers when clinicians should assess cognition and what future research may reveal.
undefined
7 snips
Oct 19, 2026 • 20min

The Menopause Transition and Epilepsy

Kelsey Smith, a Mayo Clinic neurologist and epileptologist, explores menopause care for women with epilepsy. She discusses individualized therapy, hormone treatment, seizure patterns, sleep disruption, and medication interactions, including lamotrigine. The conversation also covers bone health, osteoporosis risks, recognizing overlapping menopause and seizure symptoms, and the need for stronger research in midlife epilepsy care.
undefined
8 snips
Oct 15, 2026 • 15min

Herpes Zoster Vaccination and Incident Dementia in Canada

Pascal Geldsetzer, a Stanford physician and epidemiologist, discusses intriguing evidence linking herpes zoster vaccination with lower rates of new dementia diagnoses. He explains how natural experiments help reduce bias, why a randomized trial is needed, and what possible viral or immune mechanisms could be involved. The conversation also explores sex differences and how clinicians should discuss potential cognitive benefits without overselling them.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app